Is ceftazidime removed by hemodialysis?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: March 6, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Is Ceftazidime Dialyzable?

Yes, ceftazidime is significantly removed by hemodialysis, with approximately 50-55% of the administered dose cleared during a typical 4-hour dialysis session. 1, 2

Extent of Dialytic Removal

  • Hemodialysis removes more than half of circulating ceftazidime, reducing plasma concentrations by approximately 88% during a 6-8 hour session and by roughly 69% (from 64.3 to 20.0 mcg/mL) during a 4-hour session. 2, 3

  • The elimination half-life drops dramatically during dialysis, decreasing from 33.6 hours in anuric patients between dialysis sessions to only 2.8-3.3 hours during active hemodialysis. 2, 3

  • Dialyzer clearance of ceftazidime is approximately 55.6 mL/min, with 55% of the administered dose recovered in dialysate fluid after a single hemodialysis session. 2

Mechanism of Dialytic Clearance

  • Ceftazidime is eliminated by glomerular filtration with minimal protein binding (<10%), making it highly susceptible to removal by hemodialysis since the drug is not actively secreted by renal tubules and probenecid does not affect its elimination. 1

  • The drug's pharmacokinetic properties favor dialytic removal: low molecular weight, minimal protein binding, and lack of hepatic metabolism result in 80-90% renal excretion of unchanged drug in patients with normal kidney function. 1, 4

Recommended Dosing Strategy for Hemodialysis Patients

  • Administer 1 g IV ceftazidime immediately after each hemodialysis session for patients on a typical thrice-weekly schedule, as this timing prevents premature drug removal and ensures adequate exposure. 5, 6

  • Give the dose after dialysis, never before, to avoid significant drug loss during the dialysis session and to facilitate directly observed therapy. 5

  • A supplemental dose equal to half the usual maintenance dose should be given immediately after each dialysis session to compensate for dialytic losses. 2

Critical Dosing Pitfall to Avoid

  • Do not reduce the individual dose size; instead, extend the dosing interval to preserve ceftazidime's concentration-dependent bactericidal activity, as smaller doses may reduce drug efficacy. 5

  • Avoid administering ceftazidime before dialysis, as approximately 40% of the dose is removed when given just before hemodialysis, resulting in subtherapeutic plasma concentrations. 7

Special Considerations

  • Peritoneal dialysis also removes ceftazidime, though less efficiently than hemodialysis, and may aid in drug removal in cases of overdosage. 1, 4

  • Continuous renal replacement therapies (CRRT) extensively remove ceftazidime, with extraction coefficients around 1.0 and clearances ranging from 15-35 mL/min depending on the modality and flow rates used. 8

  • In critically ill patients or those with resistant organisms on CVVH, consider 1.25 g q8h dosing, while those on intermittent hemodialysis may require 1.25 g q24h post-dialysis. 9

References

Research

Pharmacokinetics of ceftazidime in normal and uremic subjects.

Antimicrobial agents and chemotherapy, 1984

Guideline

Ceftazidime Dosing Recommendations for Hemodialysis Patients

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Research

Important antimicrobial dosing considerations for transitions of care: Focus on thrice-weekly dosing in hemodialysis.

American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists, 2025

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Microbiologic outcomes of ceftazidime-avibactam dosing in patients with sepsis utilizing renal replacement therapies.

Hemodialysis international. International Symposium on Home Hemodialysis, 2023

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.